Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

Emiel A De Jaeghere; Sandra Tuyaerts; An M T Van Nufel; Ann Belmans; Kris Bogaerts; Regina Baiden-Amissah; Lien Lippens; Peter Vuylsteke; Stéphanie Henry; Xuan Bich Trinh; Peter A van Dam; Sandrine Aspeslagh; Alex De Caluwé; Eline Naert; Diether Lambrechts; An Hendrix; Olivier De Wever; Koen K Van de Vijver; Frédéric Amant; Katrien Vandecasteele; Hannelore G Denys

doi:10.1007/s00262-024-03873-5

Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

Cancer Immunol Immunother. 2024 Dec 30;74(1):32. doi: 10.1007/s00262-024-03873-5.

Authors

Emiel A De Jaeghere^{1

2

3}, Sandra Tuyaerts^{4

5

6

7}, An M T Van Nufel⁸, Ann Belmans⁹, Kris Bogaerts⁹, Regina Baiden-Amissah^{4

5}, Lien Lippens^{2

3}, Peter Vuylsteke¹⁰, Stéphanie Henry¹⁰, Xuan Bich Trinh^{11

12

13}, Peter A van Dam^{11

12

13}, Sandrine Aspeslagh⁶, Alex De Caluwé^{14

15}, Eline Naert^{1

2}, Diether Lambrechts¹⁶, An Hendrix^{2

3}, Olivier De Wever^{2

3}, Koen K Van de Vijver^{2

17

18}, Frédéric Amant^{4

18

19}, Katrien Vandecasteele^{2

20}, Hannelore G Denys^{21

22}

Affiliations

¹ Department of Medical Oncology (Route 535), Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium.
² Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
³ Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
⁴ Gynaecologic Oncology, Department of Oncology, KU Leuven, Louvain, Belgium.
⁵ Leuven Cancer Institute, Louvain, Belgium.
⁶ Department of Medical Oncology, University Hospital Brussels, Brussels, Belgium.
⁷ Laboratory for Medical and Molecular Oncology (LMMO), VUB, Brussels, Belgium.
⁸ Anticancer Fund (ACF), Strombeek-Bever, Belgium.
⁹ Biostatistics and Statistical Bioinformatics Centre (L-BioStat), KU Leuven, Louvain, Belgium.
¹⁰ Department of Hemato-Oncology, Centre Hospitalier Universitaire Université Catholique de Louvain Namur (Sainte-Elisabeth), Namur, Belgium.
¹¹ Department of Gynecologic Oncology and Senology, University Hospital Antwerp, Edegem, Belgium.
¹² Multidisciplinary Oncologic Centre Antwerp (MOCA), University Hospital Antwerp, Edegem, Belgium.
¹³ Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Edegem, Belgium.
¹⁴ Department of Radiation Oncology, Jules Bordet Institute, Brussels, Belgium.
¹⁵ Department of Radiation Oncology, General Hospital Sint-Maarten, Mechlin, Belgium.
¹⁶ VIB-KU Louvain Center for Cancer Biology, Leuven, Belgium.
¹⁷ Department of Pathology, Ghent University Hospital, Ghent, Belgium.
¹⁸ Center for Gynecologic Oncology Amsterdam (CGOA), Netherlands Cancer Institute and Amsterdam Medical Center, Amsterdam, The Netherlands.
¹⁹ Department of Gynecology and Obstetrics, University Hospitals Leuven, Louvain, Belgium.
²⁰ Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
²¹ Department of Medical Oncology (Route 535), Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium. [email protected].
²² Cancer Research Institute Ghent (CRIG), Ghent, Belgium. [email protected].

No abstract available

Publication types

Published Erratum